Aerovate Therapeutics (AVTE) Stockholders Approve Proposed Merger with Jade Biosciences and All Related Proposals Apr 21, 2025 08:16AM
Aerovate Therapeutics (AVTE) Declares $2.40 Special Dividend; 95.6% Yield Apr 9, 2025 04:07PM
Aerovate Therapeutics (AVTE) Announces Range of Expected Cash Dividend in Connection with the Proposed Merger with Jade Biosciences Apr 7, 2025 08:30AM
Aerovate Therapeutics (AVTE) and Jade Biosciences Announce Merger Agreement Oct 31, 2024 07:02AM
Aerovate Therapeutics (AVTE) Halted, News Pending Oct 31, 2024 07:00AM


Jul 8, 2024 08:12AM Aerovate Therapeutics (AVTE) to Explore Strategic Alternatives
Jun 17, 2024 04:06PM TD Cowen Downgrades Aerovate Therapeutics Inc (AVTE) to Hold
Jun 17, 2024 04:01PM Evercore ISI Downgrades Aerovate Therapeutics Inc (AVTE) to In Line
Jun 17, 2024 12:15PM Jefferies Downgrades Aerovate Therapeutics Inc (AVTE) to Hold
Jun 17, 2024 10:39AM BTIG Downgrades Aerovate Therapeutics Inc (AVTE) to Neutral
Jun 17, 2024 08:42AM Aerovate Therapeutics (AVTE) to Resume Trading at 9 a.m.
Jun 17, 2024 08:32AM Aerovate Therapeutics (AVTE) Reports 24-Week Topline Results from the Phase 2b Portion of IMPAHCT Trial
Jun 10, 2024 05:03PM Aerovate Therapeutics (AVTE) Files $350M Mixed Shelf
Apr 5, 2024 07:00PM These stocks are Wells Fargo's 14 high-conviction ideas for Q2